420 Magazine Background

Cannabanoid Receptor Ligands Mediate Growth Inhibition/Cell Death In Lymphoma

Julie Gardener

New Member
Cannabinoid receptor ligands mediate growth inhibition and cell death in mantle cell lymphoma​
FEBS Lett. 2005

Abstract

We have earlier reported overexpression of the central and peripheral cannabinoid receptors CB1 and CB2 in mantle cell lymphoma (MCL), a B cell non-Hodgkin lymphoma. In this study, treatment with cannabinoid receptor ligands caused a decrease in viability of MCL cells, while control cells lacking CB1 were not affected. Interestingly, equipotent doses of the CB1 antagonist SR141716A and the CB1/CB2 agonist anandamide inflicted additive negative effects on viability. Moreover, treatment with the CB1/CB2 agonist Win-55,212-2 caused a decrease in long-term growth of MCL cells in culture. Induction of apoptosis, as measured by FACS/Annexin V-FITC, contributed to the growth suppressive effect of Win-55,212-2. Our data suggest that cannabinoid receptors may be considered as potential therapeutic targets in MCL.

Source: Cannabinoid receptor ligands mediate growth inhibi... [FEBS Lett. 2005] - PubMed result
 
Last edited:
Top Bottom